The Rimonabant in treatment of Prediabetes Study: a randomised clinical trial of Rimonabant in the treatment of patients with Prediabetes - Rimonabant Study

niversity Hospitals of Leicester NHS Trust0 个研究点目标入组 300 人开始时间: 2007年6月26日最近更新: 2019年2月28日

适应症

试验速览

暂无简介。

•1) Consenting Male or female participants aged 25 to 75 years of Age
•2) BMI > 27.5 kg/m2 in South Asians, BMI >30 in White Europeans.
•3) Confirmed with Impaired Glucose tolerance and/or Impaired fasting glucose by OGTT using WHO criteria.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•1) Pregnant or breast feeding women,
•2) Absence of medically approved contraceptive usage in women of child bearing age
•3) History of eating disorders
•4) Known severe renal or hepatic impairment
•5) People with cardiac failure
•6) Severe psychiatric disorders defined as depression requiring hospitalization in the past or suicidal attempt in the past
•7) Housebound
•8) Terminally ill or already diagnosed with diabetes mellitus
•9) People currently on or in previous 3 months on anti-obesity medication.
•10) People unable to offer informed consent

发起方

niversity Hospitals of Leicester NHS Trust